Association between plasma homocysteine and peripheral arterial disease in older persons

Coronary Artery Disease

Volumn 9, Issue 1, 1998, Pages 49-50

  Aronow, Wilbert S ^a,b   Ahn, Chul ^c  

^a HEBREW HOSPITAL HOME   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Arterial occlusive disease; Folic acid; Homocysteine; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTERY DISEASE; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; RISK FACTOR; VITAMIN BLOOD LEVEL;

EID: 0031938141     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199809010-00008     Document Type: Article

References (16)

1. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274:1049-1057.
2. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332:286-291.
3. Aronow WS, Ahn C, Schoenfeld MR. Associations between plasma homocysteine and extracranial carotid arterial disease in older persons. Am J Cardiol 1997; 79:1432-1433.
4. Genest JJ Jr, McNamara JR, Salem DN, Wilson PWF, Schaefer EJ, Malinow MR. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990; 16:1114-1119.
5. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upsom B, Ullmann D, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992; 268:877-881.
6. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, et al. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 1995; 92:2825-2830.
7. 6, pyridoxal phosphate, and folate. Am J Cardiol 1995; 75:1107-1111.
8. Aronow WS, Ahn C. Association between plasma homocysteine and coronary artery disease in older persons. Am J Cardiol 1997; 80:1216-1217.
9. Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T, et al. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989; 79:1180-1188.
10. Brattstrom L, Israelsson B, Norrving B, Bergqvist D, Thorne J, Hultberg B, et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease: effects of pyridoxine and folic acid treatment. Atherosclerosis 1990; 81:51-60.
11. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324:1149-1155.
12. Molgaard J, Malinow MR, Lassvik C, Holm A-C, Upson B, Olsson AG. Hyperhomocyst(e)inemia: an independent risk factor for intermittent claudication. J Intern Med 1992; 231:273-279.
13. Bergmark C, Mansoor MA, Swedenborg J, deFaire U, Svardal AM, Ueland PM. Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50: effect of smoking and extent of disease. Eur J Vasc Surg 1993; 7:391-396.
14. Aronow WS, Sales FF, Etienne F, Lee NH. Prevalence of peripheral arterial disease and its correlation with risk factors for peripheral arterial disease in elderly patients in a long-term health care facility. Am J Cardiol 1988; 62:644-646.
15. 12 assay methods - a review. Clin Biochem 1985; 18:261-266.
16. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39:1764-1779.